Our experience
LCG Bioscience specialise in the conduct of exploratory clinical development. Our experience spans the full range of clinical pharmacology study types, across many different therapeutic areas. The majority of our work is concentrated on Phase I development where close monitoring is required to establish the properties of new molecules, many of which are being administered to humans for the first time. In addition our facilities and expertise are ideally suited to the performance of studies later in the drug development process, including method development, proof of concept and Phase IV studies.
The graphs below illustrate the mix of studies performed by LCG Bioscience since we achieved Supplementary Accreditation status in the UK’s MHRA Phase I Accreditation Scheme.
Study Types
Therapeutic Areas
